Aventria Health GroupMar 193 minHow the Quintuple Aim Can Help Life Sciences Companies SucceedNot meeting the goals of the Quintuple Aim means decision-makers will not see the value in your product. Learn how Aventria can help.
Aventria Health GroupMay 16, 20232 minThe IRA Provisions: It’s NOT Business as Usual Peter Neumann, CEVR director, discussed CMS drug negotiation provisions in the IRA and implications on a Relentless Health Value™ podcast.
Aventria Health GroupApr 20, 20233 minUnlock the Power of an Aventria Executive ThinkTank™ to Prepare for the IRA The IRA creates a game-changing set of considerations and imperatives for Pharma and the healthcare system. An Aventria Executive ThinkTank™
Aventria Health GroupMay 27, 20223 minMedicare Advantage Growth = Opportunities for Pharma to Support Patient CareThe Centers for Medicare & Medicaid Services (CMS) is transforming payment, delivery, and care in Medicare Advantage (MA) policies.